GSK is acquiring a trispecific T-cell engager from Chimagen Biosciences and Sanofi expanding its manufacturing partnership ...

A brain-boosting nutrient may sharpen your mind but knock years off your life. Research suggests the popular supplement ...

Taste is one of the five senses and a particularly powerful part in the process of food consumption. Taste is what tells ...

The trial will be conducted across the U.S. and will be the first prospective human study to test a treatment specifically ...

These appointments are complemented by other recent additions to the senior management team, including Linda Rubinstein as Chief Financial Officer, David Williams as Chief Strategy Officer, Karen ...

The Monash researchers have been working toward a whole-food version of that idea. In a 2024 formulation study, they tested breads containing 10 to 40% spinach. The highest concentration that retained ...

LONDON (AP) — An appeals court judge issued a scathing report Tuesday that found dysfunctional management and a “complete ...

Long COVID affects millions of adults in the U.S., with no FDA-approved treatment available. Bezisterim is an oral drug candidate that crosses the blood-brain barrier and is designed to reduce ...

Scientists can now get more accurate safety data by testing drugs on organ-on-a-chip devices and organoids, meaning that ...

Biodexa Enters Into Warrant Exercise Transaction for $2.3 Million in Gross ProceedsSeptember 15, 2026Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX) ...

Statistically significant benefits observed in bezisterim-treated Long COVID patients in pre-specified subgroups with high baseline fatigue, ...

BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) reported topline results from its Phase 2 ADDRESS-LC trial evaluating bezisterim, an oral investigational drug for Long COVID, showing statistically significant ...